Published in PLoS One on April 01, 2010
Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice. Toxicol Appl Pharmacol (2011) 0.89
Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice. PLoS One (2014) 0.89
Time course of gene expression profiling in the liver of experimental mice infected with Echinococcus multilocularis. PLoS One (2011) 0.84
EmTIP, a T-Cell immunomodulatory protein secreted by the tapeworm Echinococcus multilocularis is important for early metacestode development. PLoS Negl Trop Dis (2014) 0.84
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. PLoS Negl Trop Dis (2015) 0.83
An Immediate Innate Immune Response Occurred In the Early Stage of E. granulosus Eggs Infection in Sheep: Evidence from Microarray Analysis. PLoS One (2015) 0.82
Differential expressions of MHC-DQB1 mRNA in Chinese merino sheep infected with Echinococosus granuclosus. Parasitol Res (2011) 0.81
Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation. Oncotarget (2016) 0.77
Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen. PLoS Negl Trop Dis (2015) 0.76
Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions. PLoS Negl Trop Dis (2017) 0.75
Gene Expression Profile in the Liver of Sheep Infected with Cystic Echinococcosis. PLoS One (2016) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 32.08
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med (2003) 7.38
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol (2003) 3.97
Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science (2008) 2.88
Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) (2002) 2.70
Regulation of alternative macrophage activation by galectin-3. J Immunol (2008) 2.28
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest (2008) 2.26
Modulation of STAT signaling by STAT-interacting proteins. Oncogene (2000) 2.16
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 2.04
Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol (2007) 1.95
IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol (2007) 1.84
Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol (2009) 1.81
Significance testing for small microarray experiments. Stat Med (2005) 1.80
STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology (2006) 1.80
Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol (2006) 1.72
R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther (2007) 1.63
CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology (2008) 1.46
The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop (2003) 1.42
Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood (2002) 1.35
Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci U S A (2007) 1.33
Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol Chem (2007) 1.20
Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol (1990) 1.17
Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol (1996) 1.13
Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int (2005) 1.12
Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood (2003) 1.11
Enoyl-CoA hydratase. reaction, mechanism, and inhibition. Bioorg Med Chem (2003) 1.11
Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd (1986) 1.11
PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis. Science (2007) 1.10
Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J Virol (2004) 1.09
Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr (1997) 1.08
The mast cell and gut nematodes: damage and defence. Chem Immunol Allergy (2006) 1.08
Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer (2005) 1.07
Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol (2001) 1.07
CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res (2008) 1.06
Arginine residues in domain V have a central role for bacteria-binding activity of macrophage scavenger receptor MARCO. Biochem Biophys Res Commun (2002) 1.06
Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol (2008) 1.05
The effect of immunosuppression on secondary Echinococcus multilocularis infections in mice. Int J Parasitol (1976) 1.03
In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol (1998) 1.03
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology (2009) 1.01
Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun (2004) 1.00
The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J Immunol (2008) 0.99
The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol (2008) 0.97
Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J (2008) 0.96
Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite (1998) 0.94
VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog (2008) 0.94
Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells. Blood (2005) 0.92
The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis. Vaccine (2003) 0.92
Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infect Immun (2002) 0.91
Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1. Am J Pathol (2008) 0.90
Serine protease inhibitor 2A inhibits caspase-independent cell death. FEBS Lett (2004) 0.89
IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology (2003) 0.88
Secondary alveolar echinococcosis in lymphotoxin-alpha and tumour necrosis factor-alpha deficient mice: exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma. Parasite Immunol (1999) 0.88
Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis. Clin Infect Dis (1998) 0.88
Inducible nitric oxide synthase deficiency in mice increases resistance to chronic infection with Echinococcus multilocularis. Immunology (2003) 0.87
Generation of CD8+ suppressor T cells by protoscoleces of Echinococcus multilocularis in vitro. Immunology (1993) 0.87
Intestinal and systemic humoral immunological events in the susceptible Balb/C mouse strain after oral administration of Echinococcus multilocularis eggs. Parasite Immunol (1998) 0.85
Secondary Echinococcus multilocularis infection in severe combined immunodeficient (scid) mice: biphasic growth of the larval cyst mass. Int J Parasitol (1992) 0.85
Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation. Parasite Immunol (2006) 0.85
p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation. FEBS Lett (2006) 0.85
Intraperitoneal murine alveolar hydatidosis: relationship between the size of the larval cyst mass, immigrant inflammatory cells, splenomegaly and thymus involution. Tropenmed Parasitol (1983) 0.84
Expression and purification of recombinant rat eosinophil-associated ribonucleases, homologues of human eosinophil cationic protein and eosinophil-derived neurotoxin, and their characterization. Int Arch Allergy Immunol (2001) 0.83
Experimental investigations on the B and T cell immune response in primary alveolar echinococcosis. Parasite Immunol (1999) 0.82
Immune response to Echinococcus multilocularis infection in the mouse model: a review. Jpn J Vet Res (1992) 0.81
Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection. Infection (2004) 0.81
Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J Biol Chem (2002) 0.80
Echinococcus multilocularis metacestode metabolites contain a cysteine protease that digests eotaxin, a CC pro-inflammatory chemokine. Parasitol Res (2009) 0.80
Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode. Infect Immun (2009) 0.79
Reflections on the biochemistry of Echinococcus: past, present and future. Parasitology (2009) 0.78
Current trends in tissue-affecting helminths. Parasite (2008) 0.77
MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol (2010) 3.23
Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible? J Neurosurg (2013) 3.22
Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest (2005) 2.60
Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis (2002) 2.16
Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol (2008) 2.07
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
BreedVision--a multi-sensor platform for non-destructive field-based phenotyping in plant breeding. Sensors (Basel) (2013) 1.86
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines. Br J Haematol (2006) 1.54
A hypoxia complement differentiates the muscle response to endurance exercise. Exp Physiol (2010) 1.53
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Non-linearity and frequency shifts of nuclear magnetic spin-noise. J Magn Reson (2009) 1.37
Public stigma against people with mental illness in the Gilgel Gibe Field Research Center (GGFRC) in Southwest Ethiopia. PLoS One (2013) 1.36
Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis (2002) 1.28
The identification of free-living environmental isolates of amoebae from Bulgaria. Parasitol Res (2004) 1.27
Speech reception thresholds obtained in a symmetrical four-loudspeaker arrangement from bilateral users of MED-EL cochlear implants. Otol Neurotol (2002) 1.26
Selecting control genes for RT-QPCR using public microarray data. BMC Bioinformatics (2009) 1.26
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother (2007) 1.25
An ancestral secretory apparatus in the protozoan parasite Giardia intestinalis. J Biol Chem (2003) 1.23
Deep electrode insertion in cochlear implants: apical morphology, electrodes and speech perception results. Acta Otolaryngol (2003) 1.19
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis (2008) 1.19
Signal enhancement in protein NMR using the spin-noise tuning optimum. J Biomol NMR (2010) 1.18
Expression profiling with RNA from formalin-fixed, paraffin-embedded material. BMC Med Genomics (2008) 1.16
Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J Med Genet (2013) 1.16
FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J Med Chem (2010) 1.14
Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther (2011) 1.12
Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis (2003) 1.10
Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int J Parasitol (2004) 1.09
Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect Immun (2003) 1.07
In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis (2005) 1.07
Observation of NMR noise from solid samples. J Magn Reson (2010) 1.07
Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res (2006) 1.07
Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLoS Negl Trop Dis (2010) 1.07
Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. J Neuropathol Exp Neurol (2008) 1.07
Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure. Am J Cardiol (2005) 1.06
A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother (2007) 1.06
Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis (2010) 1.05
Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis. J Clin Microbiol (2008) 1.05
In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob Agents Chemother (2006) 1.05
Efficient key pathway mining: combining networks and OMICS data. Integr Biol (Camb) (2012) 1.05
Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun (2006) 1.04
Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive Disorder. World J Biol Psychiatry (2004) 1.04
Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol Genomics (2003) 1.03
Identification of cryptic Anopheles mosquito species by molecular protein profiling. PLoS One (2013) 1.03
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes. Exp Parasitol (2008) 1.02
Isolation and molecular characterization of recombinant Echinococcus granulosus P29 protein (recP29) and its assessment for the post-surgical serological follow-up of human cystic echinococcosis in young patients. Trans R Soc Trop Med Hyg (2008) 1.01
Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol (2003) 1.01
Outcomes in adults implanted with the FLEXsoft electrode. Acta Otolaryngol (2007) 1.01
Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis. J Infect Dis (2002) 1.00
Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategies. J Immunother (2010) 1.00
Rapid diagnosis of experimental meningitis by bacterial heat production in cerebrospinal fluid. BMC Infect Dis (2007) 0.99
Expression analysis of the Theileria parva subtelomere-encoded variable secreted protein gene family. PLoS One (2009) 0.99
Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp Parasitol (2003) 0.98
Health-related quality of life in patients with Gilles de la Tourette's syndrome. Mov Disord (2010) 0.98
Intestinal Tritrichomonas foetus infection in cats in Switzerland detected by in vitro cultivation and PCR. Parasitol Res (2008) 0.98
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res (2003) 0.98
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother (2007) 0.98
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists. Bioorg Med Chem (2011) 0.98
Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J Infect Dis (2004) 0.97
Tritrichomonas foetus isolates from cats and cattle show minor genetic differences in unrelated loci ITS-2 and EF-1α. Vet Parasitol (2011) 0.97
Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother (2008) 0.97
Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int J Parasitol (2002) 0.97
Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol (2003) 0.97
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci (2005) 0.97
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother (2011) 0.96
MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. J Thorac Oncol (2012) 0.96
Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol (2009) 0.96
In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infect Immun (2004) 0.96
PCR-based diagnosis of Naegleria sp. infection in formalin-fixed and paraffin-embedded brain sections. J Clin Microbiol (2006) 0.95
Screening of Swiss hot spring resorts for potentially pathogenic free-living amoebae. Exp Parasitol (2009) 0.95
Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes. J Antimicrob Chemother (2010) 0.95
Ammonium ylides for the diastereoselective synthesis of glycidic amides. Chem Commun (Camb) (2010) 0.95
Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for success. J Med Chem (2012) 0.95
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res (2006) 0.94
The association of infectious agents and schizophrenia. World J Biol Psychiatry (2010) 0.94
An infant mouse model of brain damage in pneumococcal meningitis. Acta Neuropathol (2007) 0.94
Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol (2012) 0.93
14-3-3 proteins in Echinococcus: their role and potential as protective antigens. Exp Parasitol (2008) 0.93
Detection of Leishmania RNA virus in Leishmania parasites. PLoS Negl Trop Dis (2013) 0.93
Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res (2006) 0.93
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis. Infect Immun (2014) 0.92
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.92
Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr (2006) 0.92
Spin-Noise-Detected Two-Dimensional Fourier-Transform NMR Spectroscopy. J Phys Chem Lett (2013) 0.92
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
From a library of MAG antagonists to nanomolar CD22 ligands. ChemMedChem (2011) 0.92
Non-linear signal detection improvement by radiation damping in single-pulse NMR spectra. Chemphyschem (2012) 0.92
Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives. J Agric Food Chem (2008) 0.92
Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores. BMC Cancer (2008) 0.92
In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob Agents Chemother (2005) 0.91
Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus (2003) 0.91
Endurance training modulates the muscular transcriptome response to acute exercise. Pflugers Arch (2005) 0.91